EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022

Sharlene Gill iD, Shahid Ahmed iD, Brady Anderson, Scott Berry, Howard Lim, Terry Phang iD, Ankur Sharma, Joao Paulo Solar Vasconcelos, Karamjit Gill, Mussawar Iqbal, Keith Tankel, Theresa Chan und 5 weitere

Current Oncology · 2023

DOI: 10.3390/curroncol30090579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Sharlene Gill und 16 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Eisai, Amgen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 24th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Richmond, British Columbia, on 28–29 October 2022. The WCGCCC is an interactive multidisciplinary conference attended by healthcare professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals such as dieticians, nurses and a genetic counsellor participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansBritish ColumbiaCanadaGastrointestinal Neoplasms

Stichwörter der Autor:innen

adjuvant chemotherapycolon cancercolorectal cancerimmunotherapymolecular testsrectal cancersurgery

Autor:innen und Institutionen

  • British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
  • Saskatchewan Cancer Agency, Saskatoon, SK S4W 0G3, Canada.
  • Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada.
  • Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • Central Alberta Cancer Centre, School of Medicine, University of Calgary Cumming, Red Deer, AB T4N 6R2, Canada.

ORCID-Profile: Sharlene Gill, Shahid Ahmed, Terry Phang

Förderung

  • Pfizer
  • Eisai
  • Amgen
  • Astellas Pharma
  • Incyte Corporation
  • Merck & Co.
  • Taiho Pharmaceutical,
  • BeiGene

Zitieren

APA

Gill, S., Ahmed, S., Anderson, B., Berry, S., Lim, H., Phang, T., Sharma, A., Solar Vasconcelos, J. P., Gill, K., Iqbal, M., Tankel, K., Chan, T., Recsky, M., Nuk, J., Paul, J., Mahmood, S., & Mulder, K. (2023). Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022. Current Oncology. https://doi.org/10.3390/curroncol30090579

Vancouver

Gill S, Ahmed S, Anderson B, Berry S, Lim H, Phang T, et al. Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022. Current Oncology. 2023. doi:10.3390/curroncol30090579

BibTeX
@article{Gill2023,
  author = {Gill, Sharlene and Ahmed, Shahid and Anderson, Brady and Berry, Scott and Lim, Howard and Phang, Terry and Sharma, Ankur and Solar Vasconcelos, Joao Paulo and Gill, Karamjit and Iqbal, Mussawar and Tankel, Keith and Chan, Theresa and Recsky, Magdalena and Nuk, Jennifer and Paul, James and Mahmood, Shazia and Mulder, Karen},
  title = {Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30090579}
}
Kostenlos starten →